Clinical trialNCT06121297RecruitingPhase 1/PHASE2Interventional

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

SponsorCabaletta BioEnrollment28Lupus NephritisSystemic Lupus Erythematosus

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Medical Director
Cabaletta Bio
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Maisonneuve-Rosemont Hospital
Montreal, Quebec, Canada
Caroline Lamarche, MD
Recruiting

Spain

Clinica Universitaria de Navarra
Pamplona, Navarre, Spain
Recruiting

United States

University of California Irvine
Orange, California, United States
Priyanka Iyer, MD
Recruiting
Uc Davis Health
Sacramento, California, United States
Gaurav Gulati, MD
Recruiting
Yale University
New Haven, Connecticut, United States
Fotios Koumpouras, M.D.
Recruiting
University of Florida Health
Gainesville, Florida, United States
Active, not recruiting
Mayo Clinic
Jacksonville, Florida, United States
Vikas Majithia, MBBS, MPH
Recruiting
Emory University
Atlanta, Georgia, United States
Arezou Khosroshahi, MD
Recruiting
Northwestern Memorial Hospital
Chicago, Illinois, United States
Irene Blanco, MD
Recruiting
the University of Chicago Medical Center
Chicago, Illinois, United States
Dr. Cuoghi Edens, MD, FAAP
Recruiting
University of Kansas Medical Center
Kansas City, Kansas, United States
Kimberly Liang, MD
Recruiting
Boston Children'S Hospital
Boston, Massachusetts, United States
Susan Prockop, MD
Recruiting
Brigham and Women'S Hospital
Boston, Massachusetts, United States
Elena Massarotti, MD
Recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Meghan Sise, MD
Recruiting
Tufts Medical Center
Boston, Massachusetts, United States
Andreas Klein, MD
Recruiting
Umass Memorial Hospital
Worcester, Massachusetts, United States
Roberto Caricchio, MD
Recruiting
University of Minnesota
Minneapolis, Minnesota, United States
Patrick Nachman, MD, FASN
Recruiting
Columbia University Irving Medical Center
New York, New York, United States
Withdrawn
University of Rochester
Rochester, New York, United States
Christopher Palma, MD, ScM
Recruiting
Unc Chapel Hill
Chapel Hill, North Carolina, United States
Saira Sheikh, MD
Recruiting
Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Caitlin Elgarten
Recruiting
Medical University of South Carolina
Charleston, South Carolina, United States
Melissa Cunningham, MD, PhD
Recruiting
University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Biruh Workeneh, MD, FASN
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 16 Feb 2024
Primary completion: 31 Dec 2029
Completion: 31 Dec 2029
Last update posted: 9 Apr 2026
Registered enrollment: 28
Registry id: NCT06121297

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.